|
549 Announcements
expected soon Important announcements on the future of the Royal Pharmaceutical Society’s Charter and the new community pharmacy contract were expected to be made at the end of this week, after The Journal went to press
...more
549 PSNC
announces dates for new contract roadshows The dates for the
roadshows about the new community pharmacy contract have been announced
this week by the Pharmaceutical Services Negotiating Committee ...more
549 Trigger
questions useful to identify medicines support need The inclusion
of four simple questions during the single assessment process (SAP) to
trigger referral for an in-depth medication review can have a significant
impact on the quality of patient care. This is the conclusion of a project
that published its final report this week ...more
549 SOS
appeals for money to fund legal bills with the support of seven Council
members Seven members of the Royal Pharmaceutical Society’s Council are supporting an appeal for funds to pay the costs of the four Society members whose court action ultimately led to the redrafting of the Charter currently with the Privy Council
...more
550 Pregnant
women take medicines despite risks Only 17 per cent of women
avoid taking medicines during pregnancy despite the possible risk to
the fetus, research has shown ...more
550 Pharmacists
can reassure women who have epilepsy Most women with epilepsy who continue to take antiepilepsy drugs are likely to have normal pregnancies with good outcomes, according to Hannah Cock, consultant neurologist at St George’s Hospital medical school, London
...more
550 Healthcare
Commission needs effective teeth The Healthcare Commission
should have effective teeth and ensure that guidance from the National
Institute for Clinical Excellence is implemented everywhere in England
and Wales ...more
550 Additional
funding for Agenda for Change An extra £30m will be given to NHS organisations to help fund the implementation of Agenda for Change, it was announced last week
...more
550 NHS criminal
record checks New NHS staff who may come into contact with patients will be required to have a criminal record check from early next year, Health Minister John Hutton announced this week
...more
551 New workplace
rules in force New grievance, disciplinary and dismissal rules
for all employers came into force on 1 October ...more
551 ETP will
be up and running soon Electronic prescribing is likely to
get off the ground within the next 12 months, the Prescription Pricing
Authority predicts ...more
551 NPA plans
to promote pharmacy ownership The benefits of pharmacy ownership
should be promoted more strongly by the National Pharmaceutical Association,
the NPA board decided at its meeting in September ...more
551 Hospital
pharmacies should adopt online ordering systems Hospital pharmacy
departments are not making the most of technology when it comes to managing
medicines, according to Jeff Bulmer, director of AAH Hospital Service
...more
551 NPfIT costs
balloon Procurement costs for the NHS National Programme for
Information Technology are likely to be dwarfed by the overall implementation
cost ...more
551 NPfIT chief
to leave Aidan Halligan, deputy chief medical officer and the civil servant with joint responsibility to see through the Government’s National Programme for IT (NPfIT), is to leave the Department of Health to take up a leading role in Ireland
...more
551 ETP
bulletin board Pharmweb has launched a discussion group for
pharmacists interested in electronic transmission of prescriptions ...more
|
552 Docetaxel
improves survival when hormones fail Docetaxel (Taxotere)
improves survival rates in men with advanced prostate cancer when hormone
treatment fails, data from two studies show ...more
552 Corticosteroids
raise two-week death rate Compared with placebo, the use
of corticosteroids to treat head injury is associated with an 18 per
cent higher risk of death within two weeks, a new study has shown ...more
552 DTB questions
first-line use of insulin analogues The latest issue of Drug
and Therapeutics Bulletin questions the first-line use of insulin
analogues ...more
552 Servier offers
medicines management resource pack A medicines management
resource pack has been produced by Servier Laboratories for use by pharmacists
and other health care professionals ...more
553 Exclude health
from European cross-border rules All health services should
be excluded from the scope of a proposed European directive on cross-border
services, the Pharmaceutical Group of the European Union has said ...more
553 MSD to reimburse
Vioxx prescription charge Merck Sharp & Dohme says it
will reimburse patients who paid the NHS prescription charge for their
supply of Vioxx (rofecoxib) before its withdrawal earlier this month
...more
553 EMEA to review
COX-2 heart data again Following the worldwide withdrawal
of rofecoxib (Vioxx and Vioxx Acute) earlier this month, the European
Medicines Evaluation Agency has decided to review the cardiovascular
safety of all licensed cyclo-oxygenase-2 selective inhibitors ...more
553 UK treasurer
for international pharmacy group Wally Dove, a member of the
National Pharmaceutical Association management board, was elected treasurer
of EuroPharm Forum at its annual meeting last week ...more
553 Lloyds wins
marketing award Lloydspharmacy has won a corporate social
responsibility award for its work in raising awareness of the chain’s
free diabetes testing service ...more
553 Moss expands
in Waitrose Moss Pharmacy has opened five more branches in
Waitrose stores ...more
553 Phoenix to
open 14th depot Phoenix is to open a new depot in St Albans,
Hertfordshire ...more
553 New funds
for Medway A grant of £100,000 from the Office of the
Deputy Prime Minister is to be invested in laboratories for the new Medway
school of pharmacy, at the universities of Kent and Greenwich ...more
554 Monthly ibandronate
effective Monthly treatment with the oral bisphosphonate,
ibandronate, achieves similar increases in bone mineral density in women
with post-menopausal osteoporosis as once-daily dosing, according to
data reported at meeting of the American Society for Bone Mineral Research
in Seattle earlier this month ...more
554 Green light
for six new therapies in Scotland Six therapies assessed by
the Scottish Medicines Consortium this month have been accepted for use
within NHS Scotland ...more
554 Fuzeon wins
international innovation award but Roche concerned about uptake Fuzeon
(enfuvirtide) has been recognised by the award of the 2004 International
Prix Galien to Roche, its manufacturer, for the most innovative new medicine
...more
|
The
Pharmaceutical Journal